Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06300203
PHASE2

Study of CM310 in Patients With Uncontrolled Seasonal Allergic Rhinitis

Sponsor: Beijing Tongren Hospital

View on ClinicalTrials.gov

Summary

Allergic rhinitis (AR) is a non-infectious chronic inflammatory disease of the nasal mucosa mainly mediated by immunoglobulin E after exposure to allergens in atopic individuals. The typical symptoms of AR are paroxysmal sneezing, watery rhinorrhea, itching, and nasal congestion, which may be accompanied by ocular symptoms, including eye itching, tearing, redness, and burning sensation, which are more common in patients with hay fever allergies. Bronchial asthma is associated with bronchial asthma in 40% of patients with AR, suggesting a comorbid feature of allergic disease.

Official title: The Efficacy and Safety of Humanized Antibody Targeting the Interleukin-4 Receptor Alpha Subunit (IL-4Rα) in Patients With Uncontrolled Seasonal Allergic Rhinitis Under Standard Treatment: A Randomized, Double-Blind, Placebo-controlled IIT Study

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

120

Start Date

2024-03-18

Completion Date

2026-06-30

Last Updated

2025-09-25

Healthy Volunteers

No

Interventions

BIOLOGICAL

Interleukin-4 receptor responders

Interleukin-4 receptor was injected subcutaneously.

OTHER

Placebo

Placebo was injected subcutaneously.

Locations (1)

Beijing Tongren Hospital, Capital Medical University

Beijing, Beijing Municipality, China